Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
Ozempic’s peppy ads suggest that people who use it might lose weight, but also include a disclaimer: that it “is not a weight loss drug.” Now — as Wegovy — it is.
Novo Nordisk
Coalition Hopes To Amp Up Push For Health Care Transparency
As consumers increasingly are being asked to pay a larger share of their health bills, a coalition of insurers, pharmaceutical companies, and provider and consumer advocacy groups launched Thursday a new push for greater transparency regarding the actual costs of services.
